J03.0
Conditions
Interventions
Group 1: Molecular rapid test for A-Steptococcus versus standard treatment
Group 2: Standard diagnostic and treatment
Sponsors
Sana Klinikum Lichtenberg
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: • Volunteers of both sexes between the ages of 3 and 38°C (at presentation or also reported by parents) • Non-opposition of the accompanying parent(s). • Willingness to participate in the study as evidenced by the signing of the Informed Consent Form (ICF) by the parent/guardian.
Exclusion criteria
Exclusion criteria: • Children who received antibiotics within 7 days before potential inclusion. • Children already enrolled in the study for the same episode of pharyngitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is measured as a binary event at the patient level and is the decision by the physician to prescribe antibiotics (yes/no) during the initial visit. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Number of reported sick days by the parents in the molecular POC cohort and the routine cohort within 7 days after the initial visit. 2) Number of children requiring re-assessment (for upper respiratory infection) by a physician within 7 days in the molecular POC cohort and the routine cohort. 3) Number of children that required hospitalization (all causes) within 7 days in the molecular POC cohort and the routine cohort. | — |
Countries
Germany
Contacts
Public ContactTobias Tenenbaum
Sana Klinikum Lichtenberg, Klinik für Kinder- und Jugendmedizin
Outcome results
None listed